These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12741685)

  • 1. The skeleton as a unique environment for breast cancer cells.
    Mastro AM; Gay CV; Welch DR
    Clin Exp Metastasis; 2003; 20(3):275-84. PubMed ID: 12741685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The bone microenvironment in metastasis; what is special about bone?
    Bussard KM; Gay CV; Mastro AM
    Cancer Metastasis Rev; 2008 Mar; 27(1):41-55. PubMed ID: 18071636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteolytic bone metastasis in breast cancer.
    Yoneda T; Sasaki A; Mundy GR
    Breast Cancer Res Treat; 1994; 32(1):73-84. PubMed ID: 7819589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arterial microvascularization and breast cancer colonization in bone.
    Yoneda T
    Histol Histopathol; 1997 Oct; 12(4):1145-9. PubMed ID: 9302573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenesis inhibitor TNP-470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption.
    Sasaki A; Alcalde RE; Nishiyama A; Lim DD; Mese H; Akedo H; Matsumura T
    Cancer Res; 1998 Feb; 58(3):462-7. PubMed ID: 9458090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human breast cancer cells induced angiogenesis, recruitment, and activation of osteoclasts in osteolytic metastasis.
    Winding B; Misander H; Sveigaard C; Therkildsen B; Jakobsen M; Overgaard T; Oursler MJ; Foged NT
    J Cancer Res Clin Oncol; 2000 Nov; 126(11):631-40. PubMed ID: 11079727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins may decrease skeletal-related events in breast cancer patients with bone metastases.
    Dincer M; Bulut N; Harputluoglu H; Altundag K
    Med Hypotheses; 2006; 67(5):1146-7. PubMed ID: 16844315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crosstalk between cancer cells and bone microenvironment in bone metastasis.
    Yoneda T; Hiraga T
    Biochem Biophys Res Commun; 2005 Mar; 328(3):679-87. PubMed ID: 15694401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cilengitide inhibits metastatic bone colonization in a nude rat model.
    Bretschi M; Merz M; Komljenovic D; Berger MR; Semmler W; Bäuerle T
    Oncol Rep; 2011 Oct; 26(4):843-51. PubMed ID: 21725616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New mechanistic insights of integrin β1 in breast cancer bone colonization.
    Thibaudeau L; Taubenberger AV; Theodoropoulos C; Holzapfel BM; Ramuz O; Straub M; Hutmacher DW
    Oncotarget; 2015 Jan; 6(1):332-44. PubMed ID: 25426561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors regulating the growth of metastatic cancer in bone.
    Boyce BF; Yoneda T; Guise TA
    Endocr Relat Cancer; 1999 Sep; 6(3):333-47. PubMed ID: 10516850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chemokine receptor CX₃CR1 is directly involved in the arrest of breast cancer cells to the skeleton.
    Jamieson-Gladney WL; Zhang Y; Fong AM; Meucci O; Fatatis A
    Breast Cancer Res; 2011 Sep; 13(5):R91. PubMed ID: 21933397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell line.
    Price JT; Quinn JM; Sims NA; Vieusseux J; Waldeck K; Docherty SE; Myers D; Nakamura A; Waltham MC; Gillespie MT; Thompson EW
    Cancer Res; 2005 Jun; 65(11):4929-38. PubMed ID: 15930315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acidic extracellular pH promotes prostate cancer bone metastasis by enhancing PC-3 stem cell characteristics, cell invasiveness and VEGF-induced vasculogenesis of BM-EPCs.
    Huang S; Tang Y; Peng X; Cai X; Wa Q; Ren D; Li Q; Luo J; Li L; Zou X; Huang S
    Oncol Rep; 2016 Oct; 36(4):2025-32. PubMed ID: 27498716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour progression and angiogenesis in bone metastasis from breast cancer: new approaches to an old problem.
    Pluijm G; Löwik C; Papapoulos S
    Cancer Treat Rev; 2000 Feb; 26(1):11-27. PubMed ID: 10660489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General mechanisms of metastasis.
    Woodhouse EC; Chuaqui RF; Liotta LA
    Cancer; 1997 Oct; 80(8 Suppl):1529-37. PubMed ID: 9362419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis.
    Yee AJ; Akens M; Yang BL; Finkelstein J; Zheng PS; Deng Z; Yang B
    Breast Cancer Res; 2007; 9(4):R47. PubMed ID: 17662123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone resorption and bone metastasis risk.
    Mathis KM; Sturgeon KM; Winkels RM; Wiskemann J; De Souza MJ; Schmitz KH
    Med Hypotheses; 2018 Sep; 118():36-41. PubMed ID: 30037612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer-derived factors facilitate osteolytic bone metastasis.
    Rose AA; Siegel PM
    Bull Cancer; 2006 Sep; 93(9):931-43. PubMed ID: 16980236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of marrow secretome and culture environment on the rate of metastatic breast cancer cell migration in two and three dimensions.
    Curtis KJ; Mai C; Martin H; Oberman AG; Alderfer L; Romero-Moreno R; Walsh M; Mitros SF; Thomas SG; Dynako JA; Zimmer DI; McNamara LM; Littlepage LE; Niebur GL
    Mol Biol Cell; 2021 May; 32(10):1009-1019. PubMed ID: 33689396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.